Date: Tuesday 17 Jan 2012
LONDON (ShareCast) - IMI: Exane BNP upgrades to outperform from neutral.
Smiths Group: Exane BNP upgrades to outperform from neutral.
RBS: Shore Capital upgrades to hold from sell. Oriel reiterates buy.
RSA Insurance: UBS labels short-term buy.
Resolution: UBS upgrades to buy from neutral.
Burberry: Nomura maintains buy rating and 1,530p target; Merchant Securities reiterates buy recommendation; Investec puts 1,310p target under review, buy rating kept. Bank of America-Merrill Lynch stays at neutral.
Experian: Nomura keeps buy rating and 910p target.
Marks & Spencer: Investec cuts target from 305p to 300p, hold rating retained.
Lancashire Holdings: UBS upgrades to buy.
Afren: Credit Suisse raises target from 130p to 148p, outperform rating maintained.
Greene King: Investec puts 375p target under review, sell rating unchanged; Panmure Gordon reiterates buy and 540p target.
Dixons Retail: Investec keeps hold and 10p target; Panmure Gordon maintains buy and 36p target; Credit Suisse maintains outperform rating and 25p target.
Betfair: Investec reiterates sell recommendation and 445p target.
AB Foods: Investec raises target from 1,100p to 1,180p, maintains hold.
Taylor Wimpey: Panmure Gordon reiterates buy and 50p target.
SDL: Investec initiates coverage with a buy rating and 832p target; Panmure Gordon raises target from 687p to 693p, keeps hold.
St. James's Place: Panmure Gordon reiterates buy and 400p target.
Redrow: Panmure Gordon upgrades from hold to buy, target upped from 129p to 130p.
Abcam: Investec keeps hold and 349p target.
Premier Foods: Investec maintains buy stance and 15p target.
Horizonte Minerals: Panmure Gordon cuts target price from 32p to 25p, buy rating unchanged.
Range Resources: Panmure Gordon keeps buy rating and 13.8p target.
Email this article to a friend
or share it with one of these popular networks:
| Currency | UK Pounds |
| Share Price | 1,507.00p |
| Change Today | -25.00p |
| % Change | -1.63 % |
| 52 Week High | 1,541.00 |
| 52 Week Low | 1,000.00 |
| Volume | 1,243,680 |
| Shares Issued | 442.24m |
| Market Cap | £6,664m |
| Beta | 1.69 |
| RiskGrade | 145 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 1 |
| Neutral | 18 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 26 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 03-Jul-13 | 19-Dec-12 |
| Paid | 01-Aug-13 | 25-Jan-13 |
| Amount | 21.00p | 8.00p |
| Time | Volume / Share Price |
| 15:32 | 594 @ 1,507.00p |
| 15:32 | 85 @ 1,507.00p |
| 15:32 | 220 @ 1,508.00p |
| 15:32 | 675 @ 1,508.00p |
| 15:32 | 533 @ 1,508.00p |
| Chair | John Peace |
| CFO | Stacey Cartwright |
| CEO | Angela Ahrendts |
| COO | John Smith |
You are here: research